Children achieve Time in Range mirroring well-controlled adults for the first time in real-world study of the MiniMed 780G system

Harder to manage pediatric and adolescent patients achieve 74% Time in Range, and 82% overnight Time in Range, well surpassing clinical consensus guidelines for glycemic control - Medtronic plc a leading global healthcare technology company, recently announced one-year, real-world clinical data on 3,211 pediatric and adolescent patients with type 1 diabetes 15 years old and below using the MiniMed™ 780G system 1 ...

Related Keywords

Dublin , Ireland , Kendra Cassillo , Robert Vigersky , Julie Foster , Ryan Weispfenning , Exchange Commission , D Exchange Registry , Linkedin , Drug Administration , Medtronic , Our Mission , Clinical Consensus Guidelines , Overnight Time , Advanced Hybrid Closed Loop , Exchange Registry , Active Insulin Time , Glucose Management Indicator , Customer Experience , Middle East , Diabetes Business , Diab Tech Ther , Results From , People With Type , Diab Care ,